The Clorox Company (NYSE:CLX) Shares Acquired by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC boosted its position in The Clorox Company (NYSE:CLXFree Report) by 100.8% during the 4th quarter, HoldingsChannel reports. The firm owned 11,377 shares of the company’s stock after buying an additional 5,710 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Clorox were worth $1,848,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the last quarter. Redwood Park Advisors LLC acquired a new stake in Clorox in the 4th quarter valued at approximately $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the 4th quarter valued at $31,000. Asset Planning Inc bought a new stake in Clorox during the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in Clorox during the 4th quarter worth $32,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

CLX opened at $141.99 on Wednesday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The firm has a market cap of $17.49 billion, a PE ratio of 38.80, a P/E/G ratio of 2.62 and a beta of 0.61. The business has a fifty day simple moving average of $146.19 and a 200-day simple moving average of $156.10. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the business posted $2.16 earnings per share. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.44%. Clorox’s dividend payout ratio is currently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent analyst reports. Barclays cut their price objective on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating on the stock in a research note on Friday, April 11th. Wells Fargo & Company dropped their price target on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 16th. DA Davidson reduced their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. UBS Group lowered their price objective on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research note on Thursday, April 17th. Finally, JPMorgan Chase & Co. cut their target price on Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a research report on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $153.83.

View Our Latest Analysis on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.